Top ▲
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 774 | 8p21.3 | LOXL2 | lysyl oxidase like 2 | |
Mouse | - | 776 | 14 D2 | Loxl2 | lysyl oxidase-like 2 | |
Rat | - | 776 | 15p11 | Loxl2 | lysyl oxidase-like 2 |
Previous and Unofficial Names ![]() |
LOR2 | WS9-14 | protein-lysine 6-oxidase | lysyl oxidase homolog 2 | lysyl oxidase-like 2 |
Database Links ![]() |
|
Alphafold | Q9Y4K0 (Hs), P58022 (Mm), B5DF27 (Rn) |
BRENDA | 1.4.3.13 |
CATH/Gene3D | 3.10.250.10 |
ChEMBL Target | CHEMBL3714029 (Hs), CHEMBL4105831 (Mm), CHEMBL4105908 (Rn) |
Ensembl Gene | ENSG00000134013 (Hs), ENSMUSG00000034205 (Mm), ENSRNOG00000016758 (Rn) |
Entrez Gene | 4017 (Hs), 94352 (Mm), 290350 (Rn) |
Human Protein Atlas | ENSG00000134013 (Hs) |
KEGG Enzyme | 1.4.3.13 |
KEGG Gene | hsa:4017 (Hs), mmu:94352 (Mm), rno:290350 (Rn) |
OMIM | 606663 (Hs) |
Pharos | Q9Y4K0 (Hs) |
RefSeq Nucleotide | NM_002318 (Hs), NM_033325 (Mm), NM_001106047 (Rn) |
RefSeq Protein | NP_002309 (Hs), NP_201582 (Mm), NP_001099517 (Rn) |
UniProtKB | Q9Y4K0 (Hs), P58022 (Mm), B5DF27 (Rn) |
Wikipedia | LOXL2 (Hs) |
Enzyme Reaction ![]() |
||||||||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immuno Process Associations | ||
|
General Comments |
Genetic, chemical or antibody-mediated inhibition of LOXL2 results in decreased metastasis in orthotopic and transgenic breast cancer models [1]. |
1. Barker HE, Chang J, Cox TR, Lang G, Bird D, Nicolau M, Evans HR, Gartland A, Erler JT. (2011) LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res, 71 (5): 1561-72. [PMID:21233336]
2. Harris ED, Gonnerman WA, Savage JE, O'Dell BL. (1974) Connective tissue amine oxidase. II. Purification and partial characterization of lysyl oxidase from chick aorta. Biochim Biophys Acta, 341 (2): 332-44. [PMID:4838158]
3. Leung L, Niculescu-Duvaz D, Smithen D, Lopes F, Callens C, McLeary R, Saturno G, Davies L, Aljarah M, Brown M et al.. (2019) Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships. J Med Chem, 62 (12): 5863-5884. [PMID:31070916]
4. Smith V, Ogg S, Van Vlasselaer P, Barry VE, Marshall D, Holzer AK, Rodriguez H, Oyasu M, McCauley SA, Garcia CA et al.. (2013) LOX and LOXL2 inhibitors and uses thereof. Patent number: US8461303 B2. Assignee: Gilead Biologics, Inc.. Priority date: 02/08/2007. Publication date: 11/06/2013.
5. Smithen DA, Leung LMH, Challinor M, Lawrence R, Tang H, Niculescu-Duvaz D, Pearce SP, Mcleary R, Lopes F, Aljarah M et al.. (2020) 2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth. J Med Chem, 63 (5): 2308-2324. [PMID:31430136]
1.4.3.13 Lysyl oxidases: lysyl oxidase like 2. Last modified on 11/09/2019. Accessed on 26/04/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=2853.